SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-21-006442
Filing Date
2021-02-26
Accepted
2021-02-26 17:10:39
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B5 nt10020784x4_424b5.htm 424B5 862766
2 logo_inflarx.jpg GRAPHIC 27642
3 nt10020784x4_barchart01.jpg GRAPHIC 138001
4 nt10020784x4_barchart02.jpg GRAPHIC 168415
5 nt10020784x4_flowchart01.jpg GRAPHIC 103598
6 nt10020784x4_formula1.jpg GRAPHIC 16110
7 nt10020784x4_fraction01.jpg GRAPHIC 15936
8 nt10020784x4_linechart01.jpg GRAPHIC 153118
9 nt10020784x4_linechart02.jpg GRAPHIC 179819
10 nt10020784x4_linechart03.jpg GRAPHIC 159599
  Complete submission text file 0001140361-21-006442.txt   2187459
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-239759 | Film No.: 21690941
SIC: 2834 Pharmaceutical Preparations